Benchmarking DNA Foundation Models: Biological Blind Spots inEvo2 Variant-Effect Prediction
This paper introduces a controlled benchmarking framework to evaluate DNA foundation models like Evo2, revealing systematic blind spots in their ability to capture essential biological signals and challenging their current readiness for clinical variant-effect prediction.